세계의 신장 이식 시장 규모, 점유율, 동향 분석 리포트 : 이식 유형별, 보존 방법별, 지역별, 부문별 예측(2025-2030년)

Kidney Transplant Market Size & Trends:

The global kidney transplant market size was estimated at USD 9.24 billion in 2024 and is projected to grow at a CAGR of 6.98% from 2025 to 2030. The market is driven by the increasing prevalence of end-stage renal disease (ESRD) and chronic kidney conditions worldwide, which heighten the demand for transplants. Advancements in surgical techniques, immunosuppressive drugs, and organ preservation technologies have significantly improved outcomes, further boosting the market. Rising awareness of organ donation, government initiatives, and supportive healthcare policies encourage higher transplant rates. However, challenges like organ shortages and high treatment costs persist.

The kidney transplant market is characterized by increasing demand due to the rising prevalence of chronic kidney disease (CKD) and end-stage kidney disease (ESKD), driven by underlying conditions such as diabetes and hypertension. According to the Centers for Disease Control and Prevention, 1 in 7 Americans, or 37 million people, suffer from CKD. Many are unaware of their condition until it progresses to a critical stage, requiring dialysis or a kidney transplant. Dialysis, while life-sustaining, is not a cure and comes with severe side effects, such as infection and cardiovascular strain. For these patients, kidney transplantation remains the only curative option.

However, the demand for kidneys far exceeds supply, creating a critical shortage. In the U.S. alone, over 90,000 people are currently on the kidney transplant waiting list, yet a thousand patients are removed from the list monthly because they either succumb to their illness or become too sick for transplantation. While most transplants (approximately two-thirds) come from deceased donors, living donors account for around 6,000 transplants annually. Altruistic donors, who donate to strangers, contribute only 300 to 400 kidneys each year, highlighting the challenge of finding compatible living donors. As of 2020, only 14.2% of ESKD patients had access to a living donor, further underscoring the scarcity of suitable donors.

In regions like Jordan, the shortage is exacerbated by the lack of a functional brain death donation program and limited living donors. Patients face prolonged wait times and uncertainty. To address this challenge, innovative strategies like Kidney Paired Exchange (KPE) are being implemented. KPE allows living donors who are incompatible with their intended recipient to donate their kidney to another recipient in need, creating a chain of compatible transplants. This system expands transplant opportunities for patients who would otherwise remain on the waiting list.

The kidney transplant market continues to evolve, with research and development efforts focused on alternative solutions such as xenotransplantation and 3D bioprinting to address long-term challenges. These advancements, coupled with collaborative global initiatives, aim to reduce the disparity between organ supply and demand, offering hope to millions of patients worldwide.

Global Kidney Transplant Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the kidney transplant market report based on transplant type, preservation method, and region:

• Transplant Type Outlook (Revenue, USD Million, 2018 - 2030)
• Living Donor Transplants
• Deceased Donor Transplants
  • Donation after Brain Death (DBD)
  • Donation after Circulatory Death (DCD)
• Preservation Method Outlook (Revenue, USD Million, 2018 - 2030)
• Static Cold Storage (SCS)
• Hypothermic Machine Perfusion (HMP)
• Normothermic Machine Perfusion (NMP)
• Regional Outlook (Revenue, USD Million, 2018 - 2030)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.1. Segment Definitions
  • 1.1.1. Transplant Type
  • 1.1.2. Preservation Method
  • 1.1.3. Regional scope
  • 1.1.4. Estimates and forecasts timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interviews in North America
    • 1.3.5.2. Data for primary interviews in Europe
    • 1.3.5.3. Data for primary interviews in Asia Pacific
    • 1.3.5.4. Data for primary interviews in Latin America
    • 1.3.5.5. Data for Primary interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
  • 1.6.2. Approach 1: Commodity flow approach
  • 1.6.3. Volume price analysis (Model 2)
  • 1.6.4. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Transplant Type outlook
  • 2.2.2. Preservation Method outlook
  • 2.2.3. End-use outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Kidney Transplant Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Kidney Transplant Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Kidney Transplant Market: Transplant Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Kidney Transplant Market: Transplant Type Movement Analysis
• 4.3. Kidney Transplant Market by Transplant Type Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Living Donor Transplants
  • 4.5.1. Living Donor Transplants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Deceased Donor Transplants
  • 4.6.1. Deceased Donor Transplants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.2. Donation after Brain Death (DBD)
    • 4.6.2.1. Donation after Brain Death (DBD) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.3. Donation after Circulatory Death (DCD)
    • 4.6.3.1. Donation after Circulatory Death (DCD) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Kidney Transplant Market: Preservation Method Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Kidney Transplant Market: Preservation Method Movement Analysis
• 5.3. Kidney Transplant Market by Preservation Method Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Static Cold Storage (SCS)
  • 5.5.1. Static Cold Storage (SCS) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Hypothermic Machine Perfusion (HMP)
  • 5.6.1. Hypothermic Machine Perfusion (HMP) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Normothermic Machine Perfusion (NMP)
  • 5.7.1. Normothermic Machine Perfusion (NMP) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Kidney Transplant Market: Regional Estimates & Trend Analysis

• 6.1. Regional Dashboard
• 6.2. Regional Kidney Transplant Market movement analysis
• 6.3. Kidney Transplant Market: Regional Estimates & Trend Analysis by Technology & Usability
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. North America
  • 6.5.1. North America Kidney Transplant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.2. U.S.
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Competitive Scenario
    • 6.5.2.3. Regulatory Framework
    • 6.5.2.4. Reimbursement scenario
    • 6.5.2.5. U.S. Kidney Transplant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.3. Canada
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Competitive Scenario
    • 6.5.3.3. Regulatory Framework
    • 6.5.3.4. Reimbursement scenario
    • 6.5.3.5. Canada Kidney Transplant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.4. Mexico
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Competitive Scenario
    • 6.5.4.3. Regulatory Framework
    • 6.5.4.4. Reimbursement scenario
    • 6.5.4.5. Mexico Kidney Transplant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Europe
  • 6.6.1. Europe Kidney Transplant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.2. UK
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Competitive Scenario
    • 6.6.2.3. Regulatory Framework
    • 6.6.2.4. Reimbursement scenario
    • 6.6.2.5. UK Kidney Transplant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.3. Germany
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Competitive Scenario
    • 6.6.3.3. Regulatory Framework
    • 6.6.3.4. Reimbursement scenario
    • 6.6.3.5. Germany Kidney Transplant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.4. France
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Competitive Scenario
    • 6.6.4.3. Regulatory Framework
    • 6.6.4.4. Reimbursement scenario
    • 6.6.4.5. France Kidney Transplant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.5. Italy
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Competitive Scenario
    • 6.6.5.3. Regulatory Framework
    • 6.6.5.4. Reimbursement scenario
    • 6.6.5.5. Italy Kidney Transplant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.6. Spain
    • 6.6.6.1. Key Country Dynamics
    • 6.6.6.2. Competitive Scenario
    • 6.6.6.3. Regulatory Framework
    • 6.6.6.4. Reimbursement scenario
    • 6.6.6.5. Spain Kidney Transplant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.7. Denmark
    • 6.6.7.1. Key Country Dynamics
    • 6.6.7.2. Competitive Scenario
    • 6.6.7.3. Regulatory Framework
    • 6.6.7.4. Reimbursement scenario
    • 6.6.7.5. Denmark Kidney Transplant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.8. Sweden
    • 6.6.8.1. Key Country Dynamics
    • 6.6.8.2. Competitive Scenario
    • 6.6.8.3. Regulatory Framework
    • 6.6.8.4. Reimbursement scenario
    • 6.6.8.5. Sweden Kidney Transplant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.9. Norway
    • 6.6.9.1. Key Country Dynamics
    • 6.6.9.2. Competitive Scenario
    • 6.6.9.3. Regulatory Framework
    • 6.6.9.4. Reimbursement scenario
    • 6.6.9.5. Norway Kidney Transplant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Asia Pacific
  • 6.7.1. Asia Pacific Kidney Transplant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.2. Japan
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Competitive Scenario
    • 6.7.2.3. Regulatory Framework
    • 6.7.2.4. Reimbursement scenario
    • 6.7.2.5. Japan Kidney Transplant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.3. China
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Competitive Scenario
    • 6.7.3.3. Regulatory Framework
    • 6.7.3.4. Reimbursement scenario
    • 6.7.3.5. China Kidney Transplant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.4. India
    • 6.7.4.1. Key Country Dynamics
    • 6.7.4.2. Competitive Scenario
    • 6.7.4.3. Regulatory Framework
    • 6.7.4.4. Reimbursement scenario
    • 6.7.4.5. India Kidney Transplant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.5. South Korea
    • 6.7.5.1. Key Country Dynamics
    • 6.7.5.2. Competitive Scenario
    • 6.7.5.3. Regulatory Framework
    • 6.7.5.4. Reimbursement scenario
    • 6.7.5.5. South Korea Kidney Transplant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.6. Australia
    • 6.7.6.1. Key Country Dynamics
    • 6.7.6.2. Competitive Scenario
    • 6.7.6.3. Regulatory Framework
    • 6.7.6.4. Reimbursement scenario
    • 6.7.6.5. Australia Kidney Transplant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.7. Thailand
    • 6.7.7.1. Key Country Dynamics
    • 6.7.7.2. Competitive Scenario
    • 6.7.7.3. Regulatory Framework
    • 6.7.7.4. Reimbursement scenario
    • 6.7.7.5. Thailand Kidney Transplant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.8. Latin America
  • 6.8.1. Latin America Kidney Transplant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.2. Brazil
    • 6.8.2.1. Key Country Dynamics
    • 6.8.2.2. Competitive Scenario
    • 6.8.2.3. Regulatory Framework
    • 6.8.2.4. Reimbursement scenario
    • 6.8.2.5. Brazil Kidney Transplant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.3. Argentina
    • 6.8.3.1. Key Country Dynamics
    • 6.8.3.2. Competitive Scenario
    • 6.8.3.3. Regulatory Framework
    • 6.8.3.4. Reimbursement scenario
    • 6.8.3.5. Argentina Kidney Transplant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.9. Middle East & Africa
  • 6.9.1. Middle East & Africa Kidney Transplant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9.2. South Africa
    • 6.9.2.1. Key Country Dynamics
    • 6.9.2.2. Competitive Scenario
    • 6.9.2.3. Regulatory Framework
    • 6.9.2.4. Reimbursement scenario
    • 6.9.2.5. South Africa Kidney Transplant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9.3. Saudi Arabia
    • 6.9.3.1. Key Country Dynamics
    • 6.9.3.2. Competitive Scenario
    • 6.9.3.3. Regulatory Framework
    • 6.9.3.4. Reimbursement scenario
    • 6.8.3.5. Saudi Arabia Kidney Transplant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9.4. UAE
    • 6.9.4.1. Key Country Dynamics
    • 6.9.4.2. Competitive Scenario
    • 6.9.4.3. Regulatory Framework
    • 6.9.4.4. Reimbursement scenario
    • 6.9.4.5. UAE Kidney Transplant Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9.5. Kuwait
    • 6.9.5.1. Key Country Dynamics
    • 6.9.5.2. Competitive Scenario
    • 6.9.5.3. Regulatory Framework
    • 6.9.5.4. Reimbursement scenario
    • 6.9.5.5. Kuwait Kidney Transplant Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Market Participant Categorization
• 7.2. Key Company Profiles
  • 7.2.1. TransMedics Group, Inc.
    • 7.2.1.1. Company overview
    • 7.2.1.2. Financial performance
    • 7.2.1.3. Transplant Type benchmarking
    • 7.2.1.4. Strategic initiatives
  • 7.2.2. XVIVO
    • 7.2.2.1. Company overview
    • 7.2.2.2. Financial performance
    • 7.2.2.3. Transplant Type benchmarking
    • 7.2.2.4. Strategic initiatives
  • 7.2.3. OrganOx Limited
    • 7.2.3.1. Company overview
    • 7.2.3.2. Financial performance
    • 7.2.3.3. Transplant Type benchmarking
    • 7.2.3.4. Strategic initiatives
  • 7.2.4. Paragonix Technologies
    • 7.2.4.1. Company overview
    • 7.2.4.2. Financial performance
    • 7.2.4.3. Transplant Type benchmarking
    • 7.2.4.4. Strategic initiatives
  • 7.2.5. Waters Medical Systems
    • 7.2.5.1. Company overview
    • 7.2.5.2. Financial performance
    • 7.2.5.3. Transplant Type benchmarking
    • 7.2.5.4. Strategic initiatives
  • 7.2.6. Organ Recovery Systems
    • 7.2.6.1. Company overview
    • 7.2.6.2. Financial performance
    • 7.2.6.3. Transplant Type benchmarking
    • 7.2.6.4. Strategic initiatives
  • 7.2.7. Bridge to Life Ltd.
    • 7.2.7.1. Company overview
    • 7.2.7.2. Financial performance
    • 7.2.7.3. Transplant Type benchmarking
    • 7.2.7.4. Strategic initiatives